RESEARCH ARTICLE
Sphingosine Increases ATP Release From Red Blood Cells
Francesco Misiti1, *
Article Information
Identifiers and Pagination:
Year: 2022Volume: 16
E-location ID: e1874091X2204210
Publisher ID: e1874091X2204210
DOI: 10.2174/1874091X-v16-e2204210
Article History:
Received Date: 9/9/2021Revision Received Date: 6/12/2021
Acceptance Date: 4/1/2022
Electronic publication date: 31/05/2022
Collection year: 2022

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Background:
RBC plays a pivotal role in oxygen delivery, improving distribution where it needs. When RBC enters a low oxygen area, a mechanism mediated by a signaling pathway releases ATP, responsible for vasodilatation.
Objective:
Clarify the potential role of sphingosine on the release of ATP from RBC.
Methods:
ATP release increases after sphingosine exposure in RBC under low oxygen conditions. ATP release in deoxygenated RBC shows data like that of control RBC: (1) RBC after band 3 modification by 4,4'- diisothio-cyanato-stilbene- 2,2'-disulphonic acid (DIDS); (2) CO-treated RBC.
Unlike phosphofructokinase, adenylate cyclase (AC) activity increases after exposure to sphingosine.
Results:
We show that cAMP synthesis and ATP release are not failed in sphingosine-treated red blood cells in response to incubation with mastoparan 7, forskolin plus 3-isobutyl-1-methyl xanthine, agents that stimulate cAMP synthesis.
Conclusion:
Deoxy-hemoglobin, band 3, and AC are involved in the signaling pathway responsible for ATP released after sphingosine exposure.